Patent US4056529A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4056529A Expired / Lapsed US ⏱️ 0.0 years remaining

Dibenzopyrimidoazepines

Assignee: John Wyeth and Brother Ltd
•
Filing: 1976-01-08
•
Granted: 1977-11-01
•
Expires: 1996-01-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to dibenzopyrimidoazepines of the formula (I) ##STR1## and their acid addition and quaternary ammonium salts. In formula (I) R 1 and R 2 each represent hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and X represents two hydrogen atoms, an oxo group, a protected oxo group or an oximino group. The compounds in which X represents two hydrogen atoms, an oxo group or an oximino group possess hypoglycaemic activity. The compound in which X represents a protected oxo group are intermediates for preparing the compounds in which X is an oxo group. The dibenzopyrimidoazepines may be prepared by cyclising or cyclodehydrating novel morphanthridine derivatives.

Inventors

  • 👤 Robin Michael Black

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 20:03
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04; C07D223/00; C07D223/14; C07D223/18; C07D223/20; C07D491/00; C07D491/02; C07D491/10; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 63 words
A dibenzopyrimidoazepine selected from the group consisting of compounds having the formula (I): ##STR10## and the pharmaceutically acceptable acid addition and quaternary ammonium salts thereof, wherein R 1 and R 2 each represent hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and X represents two hydrogen atoms, an oxo group, an ethylene ketal group, a di-(lower alkyl) ketal group, or an oximino group.
Claim 2
Dependent Claim 63 words
A dibenzopyrimidoazepine selected from the group consisting of compounds having the formula (I): ##STR10## and the pharmaceutically acceptable acid addition and quaternary ammonium salts thereof, wherein R 1 and R 2 each represent hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and X represents two hydrogen atoms, an oxo group, an ethylene ketal group, a di-(lower alkyl) ketal group, or an oximino group.
Claim 3
Dependent Claim 51 words
A dibenzopyrimidoazepine according to claim 1 of the formula (II) ##STR11## or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof wherein R 1 and R 2 each represent hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl and Y represents two hydrogen atoms, an oxo group or an oximino group.
Claim 4
Dependent Claim 21 words
A dibenzopyrimidoazepine according to claim 2 wherein R 1 and R 2 each represents hydrogen, lower alkyl, lower alkoxy or halogen.
Claim 5
Dependent Claim 10 words
A dibenzopyrimidoazepine according to claim 1 which is 3,4-dihydrodibenzo[c,f]pyrimido[1,2-a] azepin-10(2H)-one.
Claim 6
Dependent Claim 10 words
a dibenzopyrimidoazepine according to claim 1 which is 10-oximino-3,4-dihydro[2H]dibenzo[c,f] pyrimido[1,2-a]azepine.
Claim 7
Dependent Claim 11 words
A dibenzopyrimidoazepine according to claim 1 which is 3,4-dihydro[2H, 10H]dibenzo[c,f]pyrimido [1,2-a]azepine.

References Cited (Backward Citations)

US3646009A Cited
US3892695A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-10-31 1981-05-02 1981-11-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-10-31 1985-05-02 1985-11-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-10-31 1989-05-02 1989-11-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag